Global Alzheimer's Disease Clinical Trials Review, H2, 2018 Featuring Pfizer, J&J, Eisai Co, F. Hoffmann-La Roche, Eli Lilly and Co, Novartis, AstraZeneca, Allergan, GlaxoSmithKline & AbbVie - ResearchAndMarkets.com

The "Alzheimer's
Disease Global Clinical Trials Review, H2, 2018" clinical
trials has been added to ResearchAndMarkets.com's
offering.

"Alzheimer's Disease Global Clinical Trials Review, H2, 2018" provides
an overview of Alzheimer's Disease clinical trials scenario. This report
provides top line data relating to the clinical trials on Alzheimer's
Disease. Report includes an overview of trial numbers and their average
enrollment in top countries conducted across the globe.

The report offers coverage of disease clinical trials by region, country
(G7 & E7), phase, trial status, end points status and sponsor type.
Report also provides prominent drugs for in-progress trials (based on
number of ongoing trials). These reports are generated using a
proprietary database - Pharma eTrack Clinical trials database. Clinical
trials are collated from 80+ different clinical trial registries,
conferences, journals, news etc across the globe. Clinical trials
database undergoes periodic update by dynamic process.

Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by
  Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and
  End point status
• The report reviews top companies involved and enlists all trials
  (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated,
  Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Key Topics Covered:

1. List of Tables
2. List of Figures
3. Report Guidance
4. Clinical Trials Report Coverage
5. Clinical Trials by Region
6. Clinical Trials and Average Enrollment by Country
7. Top Five Countries Contributing to Clinical Trials in Asia-Pacific
8. Top Five Countries Contributing to Clinical Trials in Europe
9. Top Countries Contributing to Clinical Trials in North America
10. Top Five Countries Contributing to Clinical Trials in Middle East and
    Africa
11. Top Five Countries Contributing to Clinical Trials in Central and
    South America
12. Clinical Trials by G7 Countries: Proportion of Alzheimer's Disease to
    Central Nervous System Clinical Trials
13. Clinical Trials by Phase in G7 Countries
14. Clinical Trials in G7 Countries by Trial Status
15. Clinical Trials by E7 Countries: Proportion of Alzheimer's Disease to
    Central Nervous System Clinical Trials
16. Clinical Trials by Phase in E7 Countries
17. Clinical Trials in E7 Countries by Trial Status
18. Clinical Trials by Phase
19. In Progress Trials by Phase
20. Clinical Trials by Trial Status
21. Clinical Trials by End Point Status
22. Subjects Recruited Over a Period of Time
23. Clinical Trials by Sponsor Type
24. Prominent Sponsors
25. Top Companies Participating in Alzheimer's Disease Therapeutics
    Clinical Trials
26. Prominent Drugs
27. Clinical Trial Profile Snapshots
28. Appendix
    

Companies Mentioned

• Pfizer Inc
• Johnson & Johnson
• Eisai Co Ltd
• F. Hoffmann-La Roche Ltd
• Eli Lilly and Co
• Novartis AG
• AstraZeneca Plc
• Allergan Plc
• GlaxoSmithKline Plc
• AbbVie Inc

For more information about this clinical trials report visit https://www.researchandmarkets.com/research/m8h8v6/global?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190225005516/en/